AFP and hepatocellular carcinoma: Additionally, we conducted screening to identify the compounds that particularly altered the properties of AFP+/CD133+ cells as LCSC using a well-defined mixed HCC cell population and HCS imaging technology in Fa2N-4 cells (immortalized hepatocyte line) and Huh7.5 cells [18].